![]() |
市场调查报告书
商品编码
1813841
美国整形外科契约製造市场规模、份额和趋势分析报告:按类型、服务和细分市场预测,2025-2033 年U.S. Orthopedic Contract Manufacturing Market Size, Share & Trends Analysis Report By Type (Implants, Instruments, Cases, Trays), By Service (Forging/Casting, Spine & Trauma, Knee Machining & Finishing), And Segment Forecasts, 2025 - 2033 |
预计 2024 年美国整形外科契约製造市场规模为 24.8 亿美元,到 2033 年将达到 72.8 亿美元,2025 年至 2033 年的复合年增长率为 13.16%。
市场成长的动力来自于与关节重组、创伤和脊椎手术相关的手术量的增加,以及目标商标产品製造商 (OEM) 为提高效率和缩短上市时间而增加的营运外包。
此外,人口老化和运动伤害的增加也导致整形外科植入和手术器械的需求不断增加。此外,日益增长的成本压力促使原始设备製造商(OEM)更加依赖契约製造製造商进行精密加工、无尘室组装和监管支持,从而促进了整个供应链的长期合作。此外,技术创新对植入设计、器械和灭菌方法产生了显着影响。 3D列印技术发展势头强劲,尤其是在製造患者专用植入和工具方面。 PEEK、钛合金和生物可吸收材料等高性能材料的使用也日益增加。
美国整形外科契约製造市场规模及成长预测(2023-2033)
数位化製造工具、自动化和人工智慧主导的品管系统正越来越多地融入製造流程中。对创新手术器械和物联网托盘的探索也推动了医院库存管理和手术计画的改进。大量的资本投资正在增强先进的製造能力和垂直整合的服务产品。美国的受託製造厂商(CDMO) 正在获得资金,以扩大其 CNC 加工、射出成型、增材製造和无尘室包装能力。私募股权公司和原始设备製造商也在进行策略性收购和合资企业,以增强其实力并在四肢和脊椎等快速成长的领域中获得竞争优势。这些投资与对速度、扩充性和法规遵循日益增长的需求相一致。美国的监管环境复杂但定义明确,要求契约製造製造商遵守 FDA 第 820 部分(品质系统法规)和 ISO 标准。对设计可追溯性、灭菌验证和供应链风险管理的审查日益严格。
The U.S. orthopedic contract manufacturing market size was estimated at USD 2.48 billion in 2024 and is projected to reach USD 7.28 billion by 2033, growing at a CAGR of 13.16% from 2025 to 2033. The market growth is driven by increased procedural volumes related to joint reconstruction, trauma, and spine surgeries. Besides, growth is further supported by rising original equipment manufacturers (OEMs) outsourcing operations to enhance efficiency and shorten time-to-market.
In addition, the rising aging population and a growing sports injuries have contributed to the increased demand for orthopedic implants and surgical instruments. Moreover, the cost pressures have led OEMs to depend on contract manufacturers for precision machining, cleanroom assembly, and regulatory support, fueling the long-term collaborations throughout the supply chain. Besides, technological innovations have notably impacted implant design, instrumentation, and sterilization methods. 3D printing has gained momentum, particularly for creating patient-specific implants and tools. High-performance materials like PEEK, titanium alloys, and bioresorbables are increasingly being utilized.
U.S. orthopedic contract manufacturing market size and growth forecast (2023-2033)
The integration of digital manufacturing tools, automation, and AI-driven quality control systems into production processes has increased. There has also been exploration into innovative surgical instruments and IoT-enabled trays for better hospital inventory management and procedural planning. Substantial capital investments have enhanced advanced manufacturing capabilities and vertically integrated service offerings. U.S.-based contract development and manufacturing organizations (CDMOs) have received funding to expand their CNC machining, injection molding, additive manufacturing, and cleanroom packaging abilities. Private equity firms and OEMs have also engaged in strategic acquisitions and joint ventures to consolidate their strengths and achieve a competitive advantage in rapidly growing areas such as extremities and spine operations. These investments align with the increasing demand for speed, scalability, and regulatory adherence. The regulatory landscape in the U.S. is complex yet well-defined, with contract manufacturers required to adhere to the FDA's Part 820 (Quality System Regulation) and ISO standards. There has been heightened scrutiny regarding design traceability, sterilization validation, and supply chain risk management.
U.S. Orthopedic Contract Manufacturing Market Report Segmentation
This report forecasts revenue growth at country levels and analyzes the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. orthopedic contract manufacturing market report based on type, and service: